Nebula Research & Development LLC Buys New Position in Doximity, Inc. (NASDAQ:DOCS)

Nebula Research & Development LLC acquired a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 11,888 shares of the company's stock, valued at approximately $635,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DOCS. Global Retirement Partners LLC raised its holdings in Doximity by 468.1% in the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company's stock worth $29,000 after purchasing an additional 440 shares during the period. UMB Bank n.a. lifted its position in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after buying an additional 235 shares during the last quarter. Larson Financial Group LLC increased its holdings in Doximity by 49.4% in the 4th quarter. Larson Financial Group LLC now owns 756 shares of the company's stock worth $40,000 after purchasing an additional 250 shares in the last quarter. Optimum Investment Advisors acquired a new stake in shares of Doximity in the fourth quarter valued at about $43,000. Finally, Morse Asset Management Inc acquired a new position in Doximity in the third quarter valued at $46,000. Institutional investors own 87.19% of the company's stock.

Insider Transactions at Doximity

In other Doximity news, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the transaction, the director now owns 16,618 shares of the company's stock, valued at approximately $946,062.74. This trade represents a 10.74 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Timothy S. Cabral sold 20,000 shares of the business's stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares in the company, valued at approximately $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 67,000 shares of company stock worth $3,841,610. 37.40% of the stock is currently owned by corporate insiders.

Doximity Price Performance

NASDAQ:DOCS traded up $1.19 during trading hours on Friday, hitting $59.26. The stock had a trading volume of 1,434,828 shares, compared to its average volume of 1,994,243. Doximity, Inc. has a one year low of $22.96 and a one year high of $85.21. The firm has a market capitalization of $11.06 billion, a price-to-earnings ratio of 59.26, a P/E/G ratio of 4.10 and a beta of 1.41. The company has a 50 day simple moving average of $59.36 and a two-hundred day simple moving average of $56.50.

Wall Street Analyst Weigh In

Several analysts have commented on DOCS shares. Truist Financial lowered their price objective on shares of Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a research report on Thursday, April 10th. Canaccord Genuity Group upped their target price on shares of Doximity from $60.00 to $71.00 and gave the company a "hold" rating in a research note on Friday, February 7th. Needham & Company LLC raised their price target on Doximity from $65.00 to $82.00 and gave the company a "buy" rating in a report on Friday, February 7th. Morgan Stanley decreased their price target on shares of Doximity from $71.00 to $60.00 and set an "equal weight" rating for the company in a research note on Thursday, April 24th. Finally, The Goldman Sachs Group increased their price objective on Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Eleven analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $65.39.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.